latest news

Massimo Zeviani announces move to Padova

Massimo Zeviani has announced that he will leave the MBU at the end of September 2019. From 1 October, Massimo will take up a Professorship at the University of Padova in Italy, his alma mater.

With effect from 1 April 2019, Judy Hirst has been appointed as Interim Director of the MBU and she will steer the Unit forwards, until the appointment of our next Director.

Under Massimo’s directorship the Unit has formed strong links between basic science and clinical medicine, and we wish him all the very best for the future.

Rare disease day: 28 February

28 February is the twelfth international Rare Disease Day, coordinated by EURORDIS.

Around this date, awareness-raising activities are taking place all over the world.

The MBU's contribution was a mitochondrial face-painting event - great fun was had by all!

Professor Patrick Chinnery appointed as MRC Clinical Director

Congratulations to Professor Patrick Chinnery, who has been appointed as the MRC's Clinical Director.

Patrick will play a key role in developing, promoting and implementing MRC research programmes, both nationally and internationally.

Patrick is very excited about the opportunities that this new role presents for the translation of laboratory research into improvements in healthcare.

The full press release can be found on the MRC's news page.

A new drug target for tuberculosis

Professor John Walker and his colleagues have solved the first structure of an F1 domain from a bacterial pathogen family, which could lead to the development of new drugs to prevent and cure tuberculosis (TB) to follow on from the recently developed anti-TB drug Bedaquiline which targets the membrane domain of ATP synthase, and is used for treating multi-drug-resistant TB.

ATP (adenosine triphosphate) is the fuel of life and is generated in cellular organisms by an enzyme called ATP synthase.


Subscribe to MBU News